REGISTERED NUMBER: 13579259 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 April 2025

for

JBS MED LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mrs B Acharya

Mr J Joshi

Mrs S Pandya

REGISTERED OFFICE:

16 St. Johns

Enderby

Leicester

LE19 2BP

REGISTERED NUMBER:

13579259 (England and Wales)

ACCOUNTANTS:

Sterling

67 Uppingham Road

Leicester

Leicestershire

LE5 3TB

FIXED ASSETS

Intangible assets

4

1,127,000

1,288,000

Tangible assets

5

41,667

39,745

1,168,667

1,327,745

CURRENT ASSETS

Stocks

100,234

109,488

Debtors

6

343,079

276,504

Cash at bank and in hand

171,774

211,882

615,087

597,874

CREDITORS

Amounts falling due within one year

7

1,473,545

1,330,237

NET CURRENT LIABILITIES

(858,458

)

(732,363

)

TOTAL ASSETS LESS CURRENT LIABILITIES

310,209

595,382

CREDITORS

Amounts falling due after more than one year

8

-

(499,895

)

PROVISIONS FOR LIABILITIES

9

(9,379

)

(8,832

)

NET ASSETS

300,830

86,655

CAPITAL AND RESERVES

Called up share capital

300

300

Retained earnings

300,530

86,355

300,830

86,655

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 September 2025 and were signed on its behalf by:

Mr J Joshi - Director

Mrs B Acharya - Director

Mrs S Pandya - Director

1.	STATUTORY INFORMATION

JBS MED LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2022, is being amortised evenly over its estimated useful life of ten years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

15% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 22 (2024 - 22 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 May 2024

and 30 April 2025

1,610,000

AMORTISATION

At 1 May 2024

322,000

Charge for year

161,000

At 30 April 2025

483,000

NET BOOK VALUE

At 30 April 2025

1,127,000

At 30 April 2024

1,288,000

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 May 2024

51,737

Additions

7,883

At 30 April 2025

59,620

DEPRECIATION

At 1 May 2024

11,992

Charge for year

5,961

At 30 April 2025

17,953

NET BOOK VALUE

At 30 April 2025

41,667

At 30 April 2024

39,745

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.4.25

30.4.24

£

£

Trade debtors

296,562

236,457

Other debtors

46,517

40,047

343,079

276,504

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.4.25

30.4.24

£

£

Bank loans and overdrafts

-

46,104

Trade creditors

385,059

338,086

Taxation and social security

152,577

107,786

Other creditors

935,909

838,261

1,473,545

1,330,237

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

30.4.25

30.4.24

£

£

Bank loans

-

499,895

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

-

499,895

9.	PROVISIONS FOR LIABILITIES

30.4.25

30.4.24

£

£

Deferred tax

9,379

8,832

Deferred

tax

£

Balance at 1 May 2024

8,832

Provided during year

547

Balance at 30 April 2025

9,379

10.	OTHER FINANCIAL COMMITMENTS

At 30th April 2024 the company had annual commitments under non- cancellable operating leases as set out below.

Land & Buildings

Over 13 years

£ 286,000